1
|
Mandhata CP, Bishoyi AK, Sahoo CR, Maharana S, Padhy RN. Insight to biotechnological utility of phycochemicals from cyanobacterium Anabaena sp.: An overview. Fitoterapia 2023; 169:105594. [PMID: 37343687 DOI: 10.1016/j.fitote.2023.105594] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2023] [Revised: 06/12/2023] [Accepted: 06/17/2023] [Indexed: 06/23/2023]
Abstract
Cyanobacteria (blue-green algae) are well-known for the ability to excrete extra-cellular products, as a variety of cyanochemicals (phycocompounds) of curio with several extensive therapeutic applications. Among these phycocompound, the cyanotoxins from certain water-bloom forming taxa are toxic to biota, including crocodiles. Failure of current non-renewable source compounds in producing sustainable and non-toxic therapeutics led the urgency of discovering products from natural sources. Particularly, compounds of the filamentous N2-fixing Anabaena sp. have effective antibacterial, antifungal, antioxidant, and anticancer properties. Today, such newer compounds are the potential targets for the possible novel chemical scaffolds, suitable for mainstream-drug development cascades. Bioactive compounds of Anabaena sp. such as, anatoxins, hassallidins and phycobiliproteins have proven their inherent antibacterial, antifungal, and antineoplastic activities, respectively. Herein, the available details of the biomass production and the inherent phyco-constituents namely, alkaloids, lipids, phenols, peptides, proteins, polysaccharides, terpenoids and cyanotoxins are considered, along with geographical distributions and morphological characteristics of the cyanobacterium. The acquisitions of cyanochemicals in recent years have newly addressed several pharmaceutical aliments, and the understanding of the associated molecular interactions of phycochemicals have been considered, for plausible use in drug developments in future.
Collapse
Affiliation(s)
- Chinmayee Priyadarsani Mandhata
- Central Research Laboratory, Institute of Medical Science & SUM Hospital, Siksha O Anusandhan Deemed to be University, Bhubaneswar, 751003, Odisha, India
| | - Ajit Kumar Bishoyi
- Central Research Laboratory, Institute of Medical Science & SUM Hospital, Siksha O Anusandhan Deemed to be University, Bhubaneswar, 751003, Odisha, India
| | - Chita Ranjan Sahoo
- Central Research Laboratory, Institute of Medical Science & SUM Hospital, Siksha O Anusandhan Deemed to be University, Bhubaneswar, 751003, Odisha, India.
| | | | - Rabindra Nath Padhy
- Central Research Laboratory, Institute of Medical Science & SUM Hospital, Siksha O Anusandhan Deemed to be University, Bhubaneswar, 751003, Odisha, India.
| |
Collapse
|
2
|
Possible Functional Roles of Patellamides in the Ascidian-Prochloron Symbiosis. Mar Drugs 2022; 20:md20020119. [PMID: 35200648 PMCID: PMC8875616 DOI: 10.3390/md20020119] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2021] [Revised: 01/27/2022] [Accepted: 01/27/2022] [Indexed: 02/04/2023] Open
Abstract
Patellamides are highly bioactive compounds found along with other cyanobactins in the symbiosis between didemnid ascidians and the enigmatic cyanobacterium Prochloron. The biosynthetic pathway of patellamide synthesis is well understood, the relevant operons have been identified in the Prochloron genome and genes involved in patellamide synthesis are among the most highly transcribed cyanobacterial genes in hospite. However, a more detailed study of the in vivo dynamics of patellamides and their function in the ascidian-Prochloron symbiosis is complicated by the fact that Prochloron remains uncultivated despite numerous attempts since its discovery in 1975. A major challenge is to account for the highly dynamic microenvironmental conditions experienced by Prochloron in hospite, where light-dark cycles drive rapid shifts between hyperoxia and anoxia as well as pH variations from pH ~6 to ~10. Recently, work on patellamide analogues has pointed out a range of different catalytic functions of patellamide that could prove essential for the ascidian-Prochloron symbiosis and could be modulated by the strong microenvironmental dynamics. Here, we review fundamental properties of patellamides and their occurrence and dynamics in vitro and in vivo. We discuss possible functions of patellamides in the ascidian-Prochloron symbiosis and identify important knowledge gaps and needs for further experimental studies.
Collapse
|
3
|
Demirkiran O, Almaliti J, Leão T, Navarro G, Byrum T, Valeriote FA, Gerwick L, Gerwick WH. Portobelamides A and B and Caciqueamide, Cytotoxic Peptidic Natural Products from a Caldora sp. Marine Cyanobacterium. JOURNAL OF NATURAL PRODUCTS 2021; 84:2081-2093. [PMID: 34269583 DOI: 10.1021/acs.jnatprod.0c01383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Three new compounds, portobelamides A and B (1 and 2), 3-amino-2-methyl-7-octynoic acid (AMOYA) and hydroxyisovaleric acid (Hiva) containing cyclic depsipeptides, and one long chain lipopeptide caciqueamide (3), were isolated from a field-collection of a Caldora sp. marine cyanobacterium obtained from Panama as part of the Panama International Cooperative Biodiversity Group Program. Their planar structures were elucidated through analysis of 2D NMR and MS data, especially high resolution (HR) MS2/MS3 fragmentation methods. The absolute configurations of compounds 1 and 2 were deduced by traditional hydrolysis, derivative formation, and chromatographic analyses compared with standards. Portobelamide A (1) showed good cytotoxicity against H-460 human lung cancer cells (33% survival at 0.9 μM).
Collapse
Affiliation(s)
- Ozlem Demirkiran
- Department of Pharmacognosy, Faculty of Pharmacy, Trakya University, Edirne 22030, Turkey
- Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, California 92037, United States
| | - Jehad Almaliti
- Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, California 92037, United States
| | - Tiago Leão
- Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, California 92037, United States
- Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California 92093, United States
| | - Gabriel Navarro
- Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, California 92037, United States
| | - Tara Byrum
- Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, California 92037, United States
| | - Frederick A Valeriote
- Henry Ford Health System, Department of Internal Medicine, Josephine Ford Cancer Center, Detroit, Michigan 48202, United States
| | - Lena Gerwick
- Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, California 92037, United States
| | - William H Gerwick
- Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, California 92037, United States
- Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California 92093, United States
| |
Collapse
|
4
|
Darcel L, Das S, Bonnard I, Banaigs B, Inguimbert N. Thirtieth Anniversary of the Discovery of Laxaphycins. Intriguing Peptides Keeping a Part of Their Mystery. Mar Drugs 2021; 19:md19090473. [PMID: 34564135 PMCID: PMC8471579 DOI: 10.3390/md19090473] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2021] [Revised: 08/16/2021] [Accepted: 08/20/2021] [Indexed: 12/27/2022] Open
Abstract
Lipopeptides are a class of compounds generally produced by microorganisms through hybrid biosynthetic pathways involving non-ribosomal peptide synthase and a polyketyl synthase. Cyanobacterial-produced laxaphycins are examples of this family of compounds that have expanded over the past three decades. These compounds benefit from technological advances helping in their synthesis and characterization, as well as in deciphering their biosynthesis. The present article attempts to summarize most of the articles that have been published on laxaphycins. The current knowledge on the ecological role of these complex sets of compounds will also be examined.
Collapse
|
5
|
Isolation and Structure Elucidation of a Novel Symmetrical Macrocyclic Phthalate Hexaester. Symmetry (Basel) 2021. [DOI: 10.3390/sym13020361] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
A novel symmetrical macrocyclic phthalate hexaester (1) and a known macrocyclic phthalate tetraester (2) were isolated during a natural product-exploring program on the cyanobacterium Moorea producens. Their structures were elucidated based on spectroscopic data, including nuclear magnetic resonance and high-resolution mass spectra. In the antibacterial activity test, compounds 1 and 2 showed no bioactivity at the concentrations tested.
Collapse
|
6
|
Murakami A, Hayashi JI, Igawa K, Tsutsumi M, Tomooka K, Nagai H, Nehira T. Natural dolapyrrolidone: Isolation and absolute stereochemistry of a substructure of bioactive peptides. Chirality 2020; 32:1152-1159. [PMID: 32602569 DOI: 10.1002/chir.23264] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2020] [Revised: 06/13/2020] [Accepted: 06/16/2020] [Indexed: 11/09/2022]
Abstract
During the course of our chemical analysis of the hydrophilic fractions from marine cyanobacterium Moorena producens, we have isolated natural dolapyrrolidone (Dpy, 1), a natural pyrrolidone derived from phenylalanine, for the first time as a single compound. Compound 1, with an (S)-l absolute stereochemistry, was previously identified as a substructure that is common among several bioactive natural peptides. Surprisingly, the absolute stereochemistry of the isolated natural 1, determined through total synthesis, was (R)-d. This result was unambiguously determined by HPLC analysis using a chiral stationary column by comparing the retention times of the natural 1 and authentic samples of synthetic enantiomers. To verify the unexpected result, the absolute stereochemistry of the natural 1 was confirmed by X-ray crystallographic analysis of Pt-complex derivative using the synthetic enantiomer.
Collapse
Affiliation(s)
- Ayana Murakami
- Graduate School of Integrated Arts and Sciences, Hiroshima University, Higashihiroshima, Japan
| | - Jun-Ichi Hayashi
- Department of Molecular and Material Sciences, Kyushu University, Fukuoka, Japan
| | - Kazunobu Igawa
- Department of Molecular and Material Sciences, Kyushu University, Fukuoka, Japan.,Institute for Materials Chemistry and Engineering, Kyushu University, Fukuoka, Japan
| | - Miki Tsutsumi
- Department of Ocean Sciences, Tokyo University of Marine Sciences and Technology, Tokyo, Japan
| | - Katsuhiko Tomooka
- Department of Molecular and Material Sciences, Kyushu University, Fukuoka, Japan.,Institute for Materials Chemistry and Engineering, Kyushu University, Fukuoka, Japan
| | - Hiroshi Nagai
- Department of Ocean Sciences, Tokyo University of Marine Sciences and Technology, Tokyo, Japan
| | - Tatsuo Nehira
- Graduate School of Integrated Arts and Sciences, Hiroshima University, Higashihiroshima, Japan.,Graduate School of Integrated Sciences for Life, Hiroshima University, Higashihiroshima, Japan
| |
Collapse
|
7
|
Tan LT, Phyo MY. Marine Cyanobacteria: A Source of Lead Compounds and their Clinically-Relevant Molecular Targets. Molecules 2020; 25:E2197. [PMID: 32397127 PMCID: PMC7249205 DOI: 10.3390/molecules25092197] [Citation(s) in RCA: 26] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2020] [Revised: 05/03/2020] [Accepted: 05/05/2020] [Indexed: 02/07/2023] Open
Abstract
The prokaryotic filamentous marine cyanobacteria are photosynthetic microbes that are found in diverse marine habitats, ranging from epiphytic to endolithic communities. Their successful colonization in nature is largely attributed to genetic diversity as well as the production of ecologically important natural products. These cyanobacterial natural products are also a source of potential drug leads for the development of therapeutic agents used in the treatment of diseases, such as cancer, parasitic infections and inflammation. Major sources of these biomedically important natural compounds are found predominately from marine cyanobacterial orders Oscillatoriales, Nostocales, Chroococcales and Synechococcales. Moreover, technological advances in genomic and metabolomics approaches, such as mass spectrometry and NMR spectroscopy, revealed that marine cyanobacteria are a treasure trove of structurally unique natural products. The high potency of a number of natural products are due to their specific interference with validated drug targets, such as proteasomes, proteases, histone deacetylases, microtubules, actin filaments and membrane receptors/channels. In this review, the chemistry and biology of selected potent cyanobacterial compounds as well as their synthetic analogues are presented based on their molecular targets. These molecules are discussed to reflect current research trends in drug discovery from marine cyanobacterial natural products.
Collapse
Affiliation(s)
- Lik Tong Tan
- Natural Sciences and Science Education, National Institute of Education, Nanyang Technological University, Singapore 637616, Singapore;
| | | |
Collapse
|
8
|
Konstantinou D, Mavrogonatou E, Zervou SK, Giannogonas P, Gkelis S. Bioprospecting Sponge-Associated Marine Cyanobacteria to Produce Bioactive Compounds. Toxins (Basel) 2020; 12:toxins12020073. [PMID: 31979262 PMCID: PMC7076795 DOI: 10.3390/toxins12020073] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2019] [Revised: 01/20/2020] [Accepted: 01/21/2020] [Indexed: 12/23/2022] Open
Abstract
Marine cyanobacteria are considered a prolific source of bioactive natural products with a range of biotechnological and pharmacological applications. However, data on the production of natural compounds from sponge-associated cyanobacteria are scarce. This study aimed to assess the potential of sponge-associated cyanobacteria strains representing different taxonomic groups for the production of bioactive compounds and the biological activity of their extracts. Phylogenetic analysis of sponge-associated cyanobacteria and screening for the presence of genes encoding non-ribosomal peptide synthetases (NRPSs) and polyketide synthases (PKSs) were performed. Methanol extracts of the sponge-associated strains were analyzed for cyanotoxin production and tested for antioxidant activity and cytotoxic activity against several human cancer cell lines and pathogenic bacteria. PKS were detected in all sponge-associated strains examined, indicating the metabolic potential of the isolates. PKS genes were more ubiquitous than NRPS genes. Cyanotoxins (i.e., cylindrospermopsin, anatoxin-a, nodularin, and microcystins) were not detected in any of the sponge-associated cyanobacterial strains. Strains belonging to Leptothoe, Pseudanabaena, and Synechococcus were found to have activity mainly against Staphylococcus aureus. In addition, sponge-associated Leptothoe strains (TAU-MAC 0915, 1015, 1115, and 1215) were found to be highly cytotoxic and in most cases more effective against human cancer cell lines than against normal cells. Extracts with the most promising bioactivity deserve further investigation in order to isolate and identify the bioactive molecule(s).
Collapse
Affiliation(s)
- Despoina Konstantinou
- Department of Botany, School of Biology, Aristotle University of Thessaloniki, GR-541 24 Thessaloniki, Greece; (D.K.); (E.M.); (S.-K.Z.); (P.G.)
| | - Eleni Mavrogonatou
- Department of Botany, School of Biology, Aristotle University of Thessaloniki, GR-541 24 Thessaloniki, Greece; (D.K.); (E.M.); (S.-K.Z.); (P.G.)
- Laboratory of Cell Proliferation and Ageing, Institute of Biosciences & Applications, National Centre for Scientific Research “Demokritos”, Patriarchou Grigoriou & Neapoleos, Agia Paraskevi, 15341 Athens, Greece
| | - Sevasti-Kiriaki Zervou
- Department of Botany, School of Biology, Aristotle University of Thessaloniki, GR-541 24 Thessaloniki, Greece; (D.K.); (E.M.); (S.-K.Z.); (P.G.)
- Laboratory of Photo-Catalytic Processes and Environmental Chemistry, Institute of Nanoscience & Nanotechnology, National Centre for Scientific Research “Demokritos”, Patriarchou Grigoriou & Neapoleos, Agia Paraskevi, 15341 Athens, Greece
| | - Panagiotis Giannogonas
- Department of Botany, School of Biology, Aristotle University of Thessaloniki, GR-541 24 Thessaloniki, Greece; (D.K.); (E.M.); (S.-K.Z.); (P.G.)
- Laboratory of Cell Proliferation and Ageing, Institute of Biosciences & Applications, National Centre for Scientific Research “Demokritos”, Patriarchou Grigoriou & Neapoleos, Agia Paraskevi, 15341 Athens, Greece
| | - Spyros Gkelis
- Department of Botany, School of Biology, Aristotle University of Thessaloniki, GR-541 24 Thessaloniki, Greece; (D.K.); (E.M.); (S.-K.Z.); (P.G.)
- Correspondence: ; Tel.: +30-231-099-8083
| |
Collapse
|
9
|
Sousa ML, Ribeiro T, Vasconcelos V, Linder S, Urbatzka R. Portoamides A and B are mitochondrial toxins and induce cytotoxicity on the proliferative cell layer of in vitro microtumours. Toxicon 2019; 175:49-56. [PMID: 31887317 DOI: 10.1016/j.toxicon.2019.12.159] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2019] [Revised: 12/21/2019] [Accepted: 12/23/2019] [Indexed: 12/24/2022]
Abstract
Cyanobacteria are known to produce many toxins and other secondary metabolites. The study of their specific mode of action may reveal the biotechnological potential of such compounds. Portoamides A and B (PAB) are cyclic peptides isolated from the cyanobacteria Phormidium sp. due to their growth repression effect on microalgae and were shown to be cytotoxic against certain cancer cell lines. In the present work, viability was assessed on HCT116 colon cancer cells grown as monolayer culture and as multicellular spheroids (MTS), non-carcinogenic cells and on zebrafish larvae. HCT116 cells and epithelial RPE-1hTERT cells showed very similar degrees of sensitivities to PAB. PAB were able to penetrate the MTS, showing a four-fold high IC50 compared to monolayer cultures. The toxicity of PAB was similar at 4 °C and 37 °C suggesting energy-independent uptake. PAB exposure decreased ATP production, mitochondrial maximal respiration rates and induced mitochondrial membrane hyperpolarization. PAB induced general organelle stress response, indicated by an increase of the mitochondrial damage sensor PINK-1, and of phosphorylation of eIF2α, characteristic for endoplasmic reticulum stress. In summary, these findings show general toxicity of PAB on immortalized cells, cancer cells and zebrafish embryos, likely due to mitochondrial toxicity.
Collapse
Affiliation(s)
- Maria Lígia Sousa
- CIIMAR, Interdisciplinary Centre of Marine and Environmental Research, Porto, Portugal; FCUP - Faculty of Sciences of University of Porto, Porto, Portugal
| | - Tiago Ribeiro
- CIIMAR, Interdisciplinary Centre of Marine and Environmental Research, Porto, Portugal; FCUP - Faculty of Sciences of University of Porto, Porto, Portugal
| | - Vítor Vasconcelos
- CIIMAR, Interdisciplinary Centre of Marine and Environmental Research, Porto, Portugal; FCUP - Faculty of Sciences of University of Porto, Porto, Portugal
| | - Stig Linder
- Department of Oncology and Pathology, Cancer Centre Karolinska, Karolinska Institute, Stockholm, Sweden; Department of Medical and Health Sciences, Linköping University, Linköping, Sweden
| | - Ralph Urbatzka
- CIIMAR, Interdisciplinary Centre of Marine and Environmental Research, Porto, Portugal.
| |
Collapse
|
10
|
Abstract
Bioactive lipids are essential components of human cells and tissues. As discussed in this review, the cancer lipidome is diverse and malleable, with the ability to promote or inhibit cancer pathogenesis. Targeting lipids within the tumor and surrounding microenvironment may be a novel therapeutic approach for treating cancer patients. Additionally, the emergence of a novel super-family of lipid mediators termed specialized pro-resolving mediators (SPMs) has revealed a new role for bioactive lipid mediators in the resolution of inflammation in cancer biology. The role of SPMs in cancer holds great promise in our understanding of cancer pathogenesis and can ultimately be used in future cancer diagnostics and therapy.
Collapse
Affiliation(s)
- Megan L Sulciner
- Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
- Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
| | - Allison Gartung
- Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
- Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
| | - Molly M Gilligan
- Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
- Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
| | - Charles N Serhan
- Department of Anesthesiology, Center for Experimental Therapeutics and Reperfusion Injury, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Dipak Panigrahy
- Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
- Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
| |
Collapse
|
11
|
Xie S, Bernhardt PV, Gahan LR, Williams CM. Contemplating 1,2,4-Thiadiazole-Inspired Cyclic Peptide Mimics: A Computational Investigation. Aust J Chem 2019. [DOI: 10.1071/ch19248] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
Marine derived cyclic peptides have inspired chemists for decades as the cavitand architecture can be compared with macrocyclic ligands, and hence easily conceived as mediators of metal-ion transport. Lissoclinamide 5 and ascidiacyclamide are two such cyclic peptides that have received much attention both for their metal ion complexation properties and biological activity; the metal ion binding properties of mimics of these two systems have been reported. Reported herein is a computational study aimed at evaluating the stability, and potential for copper(ii) ion binding by lissoclinamide 5 mimics that substitute the naturally occurring 4-carboxy-1,3-thiazole units for novel valine- and phenylalanine-derived 1,2,4-thiadiazole units. Our results suggest that one lissoclinamide 5 mimic, 1,2,4-thiadiazole (TDA)-lissoclinamide 9, may be capable of forming a complex with one CuII ion, [Cu(9-H)(H2O)]+. A complex with two CuII ions, [Cu2(9-H)(μ-OH)]2+, was also considered. These results set the stage for synthetic and experimental metal binding studies.
Collapse
|
12
|
Bertin MJ, Saurí J, Liu Y, Via CW, Roduit AF, Williamson RT. Trichophycins B-F, Chlorovinylidene-Containing Polyketides Isolated from a Cyanobacterial Bloom. J Org Chem 2018; 83:13256-13266. [PMID: 30280904 DOI: 10.1021/acs.joc.8b02070] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
NMR-guided isolation (based on 1D 1H and 13C NMR resonances consistent with a chlorovinylidene moiety) resulted in the characterization of five new highly functionalized polyketides, trichophycins B-F (1-5), and one nonchlorinated metabolite tricholactone (6) from a collection of Trichodesmium bloom material from the Gulf of Mexico. The planar structures of 1-6 were determined using 1D and 2D NMR spectroscopy, mass spectrometry, and complementary spectroscopic procedures. Absolute configuration analysis of 1 and 2 were carried out by 1H NMR analysis of diastereomeric Mosher esters in addition to ECD spectroscopy, J-based configuration analysis, and DFT calculations. The absolute configurations of 3-6 were proposed on the basis of comparative analysis of 13C NMR chemical shifts, relative configurations, and optical rotation values to compounds 1 and 2. Compounds 1-5 represent new additions to the trichophycin family and are hallmarked by a chlorovinylidene moiety. These new trichophycins and tricholactone (1-6) feature intriguing variations with respect to putative biosynthetic starting units, halogenation, and terminations, and trichophycin E (4) features a rare alkynyl bromide functionality. The phenyl-containing trichophycins showed low cytotoxicity to neuro-2A cells, while the alkyne-containing trichophycins showed no toxicity.
Collapse
Affiliation(s)
- Matthew J Bertin
- Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy , University of Rhode Island , 7 Greenhouse Road , Kingston , Rhode Island 02881 , United States
| | - Josep Saurí
- Structure Elucidation Group, Process and Analytical Research and Development , Merck and Co. Inc , 33 Avenue Louis Pasteur , Boston , Massachusetts 02115 , United States
| | - Yizhou Liu
- Structure Elucidation Group, Process and Analytical Research and Development , Merck and Co. Inc , 126 East Lincoln Avenue , Rahway , New Jersey 07065 , United States
| | - Christopher W Via
- Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy , University of Rhode Island , 7 Greenhouse Road , Kingston , Rhode Island 02881 , United States
| | - Alexandre F Roduit
- Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy , University of Rhode Island , 7 Greenhouse Road , Kingston , Rhode Island 02881 , United States
| | - R Thomas Williamson
- Structure Elucidation Group, Process and Analytical Research and Development , Merck and Co. Inc , 126 East Lincoln Avenue , Rahway , New Jersey 07065 , United States
| |
Collapse
|
13
|
Gallegos DA, Saurí J, Cohen RD, Wan X, Videau P, Vallota-Eastman AO, Shaala LA, Youssef DTA, Williamson RT, Martin GE, Philmus B, Sikora AE, Ishmael JE, McPhail KL. Jizanpeptins, Cyanobacterial Protease Inhibitors from a Symploca sp. Cyanobacterium Collected in the Red Sea. JOURNAL OF NATURAL PRODUCTS 2018; 81:1417-1425. [PMID: 29808677 PMCID: PMC7847313 DOI: 10.1021/acs.jnatprod.8b00117] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
Jizanpeptins A-E (1-5) are micropeptin depsipeptides isolated from a Red Sea specimen of a Symploca sp. cyanobacterium. The planar structures of the jizanpeptins were established using NMR spectroscopy and mass spectrometry and contain 3-amino-6-hydroxy-2-piperidone (Ahp) as one of eight residues in a typical micropeptin motif, as well as a side chain terminal glyceric acid sulfate moiety. The absolute configurations of the jizanpeptins were assigned using a combination of Marfey's methodology and chiral-phase HPLC analysis of hydrolysis products compared to commercial and synthesized standards. Jizanpeptins A-E showed specific inhibition of the serine protease trypsin (IC50 = 72 nM to 1 μM) compared to chymotrypsin (IC50 = 1.4 to >10 μM) in vitro and were not overtly cytotoxic to HeLa cervical or NCI-H460 lung cancer cell lines at micromolar concentrations.
Collapse
Affiliation(s)
- David A. Gallegos
- Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon 97331, United States
| | - Josep Saurí
- Structure Elucidation Group, Process and Analytical Research and Development, Merck & Co., Inc., 33 Avenue Louis Pasteur, Boston, Massachusetts 02115, United States
| | - Ryan D. Cohen
- Structure Elucidation Group, Process and Analytical Research and Development, Merck & Co., Inc.,126 East Lincoln Avenue, Rahway, New Jersey 07065, United States
| | - Xuemei Wan
- Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon 97331, United States
| | - Patrick Videau
- Department of Biology, College of Arts and Sciences, Dakota State University, Madison, SD 57042
| | - Alec O. Vallota-Eastman
- Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon 97331, United States
| | - Lamiaa A. Shaala
- Suez Canal University Hospital, Suez Canal University, Ismailia 41522, Egypt
| | - Diaa T. A. Youssef
- Department of Natural Products, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia
| | - R. Thomas Williamson
- Structure Elucidation Group, Process and Analytical Research and Development, Merck & Co., Inc.,126 East Lincoln Avenue, Rahway, New Jersey 07065, United States
| | - Gary E. Martin
- Structure Elucidation Group, Process and Analytical Research and Development, Merck & Co., Inc.,126 East Lincoln Avenue, Rahway, New Jersey 07065, United States
| | - Benjamin Philmus
- Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon 97331, United States
| | - Aleksandra E. Sikora
- Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon 97331, United States
| | - Jane E. Ishmael
- Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon 97331, United States
| | - Kerry L. McPhail
- Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon 97331, United States
| |
Collapse
|
14
|
Xie S, Savchenko AI, Krenske EH, Grange RL, Gahan LR, Williams CM. Developing Cyclic Peptide Heteroatom Interchange: Synthesis and DFT Modelling of a HI‐Ascidiacyclamide Isomer. European J Org Chem 2018. [DOI: 10.1002/ejoc.201800449] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Affiliation(s)
- Sida Xie
- School of Chemistry and Molecular Biosciences University of Queensland 4072 Brisbane Australia
- Southwest Forestry University 650224 Kunming P. R. China
| | - Andrei I. Savchenko
- School of Chemistry and Molecular Biosciences University of Queensland 4072 Brisbane Australia
| | - Elizabeth H. Krenske
- School of Chemistry and Molecular Biosciences University of Queensland 4072 Brisbane Australia
| | - Rebecca L. Grange
- School of Chemistry and Molecular Biosciences University of Queensland 4072 Brisbane Australia
| | - Lawrence R. Gahan
- School of Chemistry and Molecular Biosciences University of Queensland 4072 Brisbane Australia
| | - Craig M. Williams
- School of Chemistry and Molecular Biosciences University of Queensland 4072 Brisbane Australia
| |
Collapse
|
15
|
Cai W, Matthew S, Chen QY, Paul VJ, Luesch H. Discovery of new A- and B-type laxaphycins with synergistic anticancer activity. Bioorg Med Chem 2018; 26:2310-2319. [PMID: 29606488 PMCID: PMC6084785 DOI: 10.1016/j.bmc.2018.03.022] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2018] [Revised: 03/03/2018] [Accepted: 03/12/2018] [Indexed: 02/01/2023]
Abstract
Two new cyclic lipopeptides termed laxaphycins B4 (1) and A2 (2) were discovered from a collection of the marine cyanobacterium Hormothamnion enteromorphoides, along with the known compound laxaphycin A. The planar structures were solved based on a combined interpretation of 1D and 2D NMR data and mass spectral data. The absolute configurations of the subunits were determined by chiral LC-MS analysis of the hydrolysates, advanced Marfey's analysis and 1D and 2D ROESY experiments. Consistent with similar findings on other laxaphycin A- and B-type peptides, laxaphycin B4 (1) showed antiproliferative effects against human colon cancer HCT116 cells with IC50 of 1.7 µM, while laxaphycins A and A2 (2) exhibited weak activities. The two major compounds isolated from the sample, laxaphycins A and B4, were shown to act synergistically to inhibit the growth of HCT116 colorectal cancer cells.
Collapse
Affiliation(s)
- Weijing Cai
- Department of Medicinal Chemistry, University of Florida, 1345 Center Drive, Gainesville, FL 32610, United States; Center for Natural Products, Drug Discovery and Development (CNPD3), University of Florida, 1345 Center Drive, Gainesville, FL 32610, United States
| | - Susan Matthew
- Department of Medicinal Chemistry, University of Florida, 1345 Center Drive, Gainesville, FL 32610, United States
| | - Qi-Yin Chen
- Department of Medicinal Chemistry, University of Florida, 1345 Center Drive, Gainesville, FL 32610, United States; Center for Natural Products, Drug Discovery and Development (CNPD3), University of Florida, 1345 Center Drive, Gainesville, FL 32610, United States
| | - Valerie J Paul
- Smithsonian Marine Station, Fort Pierce, FL 34949, United States
| | - Hendrik Luesch
- Department of Medicinal Chemistry, University of Florida, 1345 Center Drive, Gainesville, FL 32610, United States; Center for Natural Products, Drug Discovery and Development (CNPD3), University of Florida, 1345 Center Drive, Gainesville, FL 32610, United States.
| |
Collapse
|
16
|
Xie S, Savchenko AI, Kerscher M, Grange RL, Krenske EH, Harmer JR, Bauer MJ, Broit N, Watters DJ, Boyle GM, Bernhardt PV, Parsons PG, Comba P, Gahan LR, Williams CM. Heteroatom-Interchanged Isomers of Lissoclinamide 5: Copper(II) Complexation, Halide Binding, and Biological Activity. European J Org Chem 2018. [DOI: 10.1002/ejoc.201701659] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- Sida Xie
- School of Chemistry and Molecular Biosciences; The University of Queensland; 4072 Brisbane Queensland Australia
- Southwest Forestry University; 650224 Kunming P. R. China
| | - Andrei I. Savchenko
- School of Chemistry and Molecular Biosciences; The University of Queensland; 4072 Brisbane Queensland Australia
| | - Marion Kerscher
- Anorganisch-Chemisches Institut and Interdisciplinary Centre for Scientific Computing; Universität Heidelberg; INF 270; 69120 Heidelberg Germany
| | - Rebecca L. Grange
- School of Chemistry and Molecular Biosciences; The University of Queensland; 4072 Brisbane Queensland Australia
| | - Elizabeth H. Krenske
- School of Chemistry and Molecular Biosciences; The University of Queensland; 4072 Brisbane Queensland Australia
| | - Jeffrey R. Harmer
- Center for Advanced Imaging; The University of Queensland; 4072 Brisbane Queensland Australia
| | - Michelle J. Bauer
- QIMR Berghofer Medical Research Institute; PO Royal Brisbane Hospital; 4029 Brisbane Queensland Australia
| | - Natasa Broit
- QIMR Berghofer Medical Research Institute; PO Royal Brisbane Hospital; 4029 Brisbane Queensland Australia
| | - Dianne J. Watters
- School of Environment and Science; Griffith University; 4111 Brisbane QLD Australia
| | - Glen M. Boyle
- QIMR Berghofer Medical Research Institute; PO Royal Brisbane Hospital; 4029 Brisbane Queensland Australia
| | - Paul V. Bernhardt
- School of Chemistry and Molecular Biosciences; The University of Queensland; 4072 Brisbane Queensland Australia
| | - Peter G. Parsons
- QIMR Berghofer Medical Research Institute; PO Royal Brisbane Hospital; 4029 Brisbane Queensland Australia
| | - Peter Comba
- Anorganisch-Chemisches Institut and Interdisciplinary Centre for Scientific Computing; Universität Heidelberg; INF 270; 69120 Heidelberg Germany
| | - Lawrence R. Gahan
- School of Chemistry and Molecular Biosciences; The University of Queensland; 4072 Brisbane Queensland Australia
| | - Craig M. Williams
- School of Chemistry and Molecular Biosciences; The University of Queensland; 4072 Brisbane Queensland Australia
| |
Collapse
|
17
|
Mayer AMS, Rodríguez AD, Taglialatela-Scafati O, Fusetani N. Marine Pharmacology in 2012-2013: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action. Mar Drugs 2017; 15:md15090273. [PMID: 28850074 PMCID: PMC5618412 DOI: 10.3390/md15090273] [Citation(s) in RCA: 67] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2017] [Revised: 08/17/2017] [Accepted: 08/21/2017] [Indexed: 12/23/2022] Open
Abstract
The peer-reviewed marine pharmacology literature from 2012 to 2013 was systematically reviewed, consistent with the 1998–2011 reviews of this series. Marine pharmacology research from 2012 to 2013, conducted by scientists from 42 countries in addition to the United States, reported findings on the preclinical pharmacology of 257 marine compounds. The preclinical pharmacology of compounds isolated from marine organisms revealed antibacterial, antifungal, antiprotozoal, antituberculosis, antiviral and anthelmitic pharmacological activities for 113 marine natural products. In addition, 75 marine compounds were reported to have antidiabetic and anti-inflammatory activities and affect the immune and nervous system. Finally, 69 marine compounds were shown to display miscellaneous mechanisms of action which could contribute to novel pharmacological classes. Thus, in 2012–2013, the preclinical marine natural product pharmacology pipeline provided novel pharmacology and lead compounds to the clinical marine pharmaceutical pipeline, and contributed significantly to potentially novel therapeutic approaches to several global disease categories.
Collapse
Affiliation(s)
- Alejandro M S Mayer
- Department of Pharmacology, Chicago College of Osteopathic Medicine, Midwestern University, 555 31st Street, Downers Grove, IL 60515, USA.
| | - Abimael D Rodríguez
- Molecular Sciences Research Center, University of Puerto Rico, 1390 Ponce de León Avenue, San Juan, PR 00926, USA.
| | | | | |
Collapse
|
18
|
Bertin MJ, Roduit AF, Sun J, Alves GE, Via CW, Gonzalez MA, Zimba PV, Moeller PDR. Tricholides A and B and Unnarmicin D: New Hybrid PKS-NRPS Macrocycles Isolated from an Environmental Collection of Trichodesmium thiebautii. Mar Drugs 2017; 15:E206. [PMID: 28665343 PMCID: PMC5532648 DOI: 10.3390/md15070206] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2017] [Revised: 06/10/2017] [Accepted: 06/27/2017] [Indexed: 01/02/2023] Open
Abstract
Bioassay-guided isolation of the lipophilic extract of Trichodesmium thiebautii bloom material led to the purification and structure characterization of two new hybrid polyketide-non-ribosomal peptide (PKS-NRPS) macrocyclic compounds, tricholides A and B (1 and 2). A third macrocyclic compound, unnarmicin D (3), was identified as a new depsipeptide in the unnarmicin family, given its structural similarity to the existing compounds in this group. The planar structures of 1-3 were determined using 1D and 2D NMR spectra and complementary spectroscopic and spectrometric procedures. The absolute configurations of the amino acid components of 1-3 were determined via acid hydrolysis, derivitization with Marfey's reagent and HPLC-UV comparison to authentic amino acid standards. The absolute configuration of the 3-hydroxydodecanoic acid moiety in 3 was determined using a modified Mosher's esterification procedure on a linear derivative of tricharmicin (4) and additionally by a comparison of 13C NMR shifts of 3 to known depsipeptides with β-hydroxy acid subunits. Tricholide B (2) showed moderate cytotoxicity to Neuro-2A murine neuroblastoma cells (EC50: 14.5 ± 6.2 μM).
Collapse
Affiliation(s)
- Matthew J Bertin
- Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.
| | - Alexandre F Roduit
- Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.
| | - Jiadong Sun
- Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.
| | - Gabriella E Alves
- Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.
| | - Christopher W Via
- Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.
| | - Miguel A Gonzalez
- Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.
| | - Paul V Zimba
- Center for Coastal Studies and Department of Life Sciences, Texas A&M Corpus Christi, 6300 Ocean Drive, Corpus Christi, TX 78412, USA.
| | - Peter D R Moeller
- Emerging Toxins Program, National Ocean Service/NOAA, Hollings Marine Laboratory, 331 Fort Johnson Road, Charleston, SC 29412, USA.
| |
Collapse
|
19
|
Jiang W, Zhou W, Othman R, Uchida H, Watanabe R, Suzuki T, Sakamoto B, Nagai H. A new malyngamide from the marine cyanobacterium Moorea producens. Nat Prod Res 2017; 32:97-104. [PMID: 28595450 DOI: 10.1080/14786419.2017.1338282] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
A new malyngamide (1) was isolated along with seven known compounds (2-8) from the marine cyanobacterium Moorea producens collected in Hawaii. Compound 1 represented the first reported malyngamide with a hydroxy moiety at C-7 of the characteristic fatty acid portion of the compound. Compound 1 showed cytotoxicity against L1210 cell line at an IC50 value of 2.9 mM and lethal toxicity against the shrimp Palaemon paucidens at a LD100 value of 33.3 mg/kg. The bioactivity of compound 1 was approximately 10-100 times weaker than those of isomalyngamides A and B (3, 4). These results indicated that the methoxy group at C-7 of the fatty acid section confers a degree of bioactivity in malyngamides.
Collapse
Affiliation(s)
- Weina Jiang
- a Department of Ocean Sciences , Tokyo University of Marine Science and Technology , Tokyo , Japan
| | - Wei Zhou
- a Department of Ocean Sciences , Tokyo University of Marine Science and Technology , Tokyo , Japan
| | - Raymie Othman
- a Department of Ocean Sciences , Tokyo University of Marine Science and Technology , Tokyo , Japan
| | - Hajime Uchida
- b National Research Institute of Fisheries Science , Yokohama , Japan
| | - Ryuichi Watanabe
- b National Research Institute of Fisheries Science , Yokohama , Japan
| | - Toshiyuki Suzuki
- b National Research Institute of Fisheries Science , Yokohama , Japan
| | - Bryan Sakamoto
- c Richard L. Roudebush VA Medical Center , Indianapolis , USA
| | - Hiroshi Nagai
- a Department of Ocean Sciences , Tokyo University of Marine Science and Technology , Tokyo , Japan
| |
Collapse
|
20
|
Anjum K, Abbas SQ, Akhter N, Shagufta BI, Shah SAA, Hassan SSU. Emerging biopharmaceuticals from bioactive peptides derived from marine organisms. Chem Biol Drug Des 2017; 90:12-30. [PMID: 28004491 DOI: 10.1111/cbdd.12925] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2016] [Revised: 10/27/2016] [Accepted: 12/11/2016] [Indexed: 12/16/2022]
Abstract
Biologically active natural products are spontaneous medicinal entrants, which encourage synthetic access for enhancing and supporting drug discovery and development. Marine bioactive peptides are considered as a rich source of natural products that may provide long-term health, in addition to many prophylactic and curative medicinal drug treatments. The large literature concerning marine peptides has been collected, which shows high potential of nutraceutical and therapeutic efficacy encompassing wide spectra of bioactivities against a number of infection-causing agents. Their antimicrobial, antimalarial, antitumor, antiviral, and cardioprotective actions have achieved the attention of the pharmaceutical industry toward new design of drug formulations, for treatment and prevention of several infections. However, the mechanism of action of many peptide molecules has been still untapped. So in this regard, this paper reviews several peptide compounds by which they interfere with human pathogenesis. This knowledge is one of the key tools to be understood especially for the biotransformation of biomolecules into targeted medicines. The fact that different diseases have the capability to fight at different sites inside the body can lead to a new wave of increasing the chances to produce targeted medicines.
Collapse
Affiliation(s)
- Komal Anjum
- Ocean College, Zhejiang University, Hangzhou, China
| | - Syed Qamar Abbas
- Faculty of Pharmacy, Gomal University, D.I. Khan, Khyber-Pakhtunkhwa, Pakistan
| | | | - Bibi Ibtesam Shagufta
- Department of Zoology, Kohat University of Science and Technology (KUST), D.I. Khan, Khyber-Pakhtunkhwa, Pakistan
| | | | | |
Collapse
|
21
|
Wang YJ, Li YY, Liu XY, Lu XL, Cao X, Jiao BH. Marine Antibody-Drug Conjugates: Design Strategies and Research Progress. Mar Drugs 2017; 15:E18. [PMID: 28098746 PMCID: PMC5295238 DOI: 10.3390/md15010018] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2016] [Revised: 12/30/2016] [Accepted: 01/04/2017] [Indexed: 01/22/2023] Open
Abstract
Antibody-drug conjugates (ADCs), constructed with monoclonal antibodies (mAbs), linkers, and natural cytotoxins, are innovative drugs developed for oncotherapy. Owing to the distinctive advantages of both chemotherapy drugs and antibody drugs, ADCs have obtained enormous success during the past several years. The development of highly specific antibodies, novel marine toxins' applications, and innovative linker technologies all accelerate the rapid R&D of ADCs. Meanwhile, some challenges remain to be solved for future ADCs. For instance, varieties of site-specific conjugation have been proposed for solving the inhomogeneity of DARs (Drug Antibody Ratios). In this review, the usages of various natural toxins, especially marine cytotoxins, and the development strategies for ADCs in the past decade are summarized. Representative ADCs with marine cytotoxins in the pipeline are introduced and characterized with their new features, while perspective comments for future ADCs are proposed.
Collapse
Affiliation(s)
- Yu-Jie Wang
- Department of Biochemistry and Molecular Biology, Second Military Medical University, Shanghai 200433, China.
- Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, China.
| | - Yu-Yan Li
- Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, China.
| | - Xiao-Yu Liu
- Department of Biochemistry and Molecular Biology, Second Military Medical University, Shanghai 200433, China.
| | - Xiao-Ling Lu
- Department of Biochemistry and Molecular Biology, Second Military Medical University, Shanghai 200433, China.
| | - Xin Cao
- Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 200032, China.
| | - Bing-Hua Jiao
- Department of Biochemistry and Molecular Biology, Second Military Medical University, Shanghai 200433, China.
| |
Collapse
|
22
|
Bertin MJ, Wahome PG, Zimba PV, He H, Moeller PDR. Trichophycin A, a Cytotoxic Linear Polyketide Isolated from a Trichodesmium thiebautii Bloom. Mar Drugs 2017; 15:E10. [PMID: 28067831 PMCID: PMC5295230 DOI: 10.3390/md15010010] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2016] [Revised: 12/28/2016] [Accepted: 12/30/2016] [Indexed: 01/30/2023] Open
Abstract
In an effort to isolate and characterize bioactive secondary metabolites from Trichodesmium thiebautii blooms, collected cyanobacteria biomass was subjected to bioassay-guided extraction and fractionation using the human colon cancer cell line HCT-116, resulting in the isolation and subsequent structure characterization of a linear polyketide trichophycin A (1). The planar structure of 1 was completed using 1D and 2D NMR spectroscopy and high-resolution electrospray ionization mass spectrometry (HRESIMS). Trichophycin A was moderately toxic against the murine neuroblastoma cell line Neuro-2A (EC50: 6.5 μM) and HCT-116 cells (EC50: 11.7 μM). Trichophycin A was significantly more cytotoxic than the previously isolated polyketides trichotoxin A and trichotoxin B. These cytotoxicity observations suggest that toxicity may be related to the polyol character of these polyketide compounds.
Collapse
Affiliation(s)
- Matthew J Bertin
- Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 7 Greenhouse Road, Kingston, RI 02881, USA.
| | - Paul G Wahome
- Biosortia Pharmaceuticals, Hollings Marine Laboratory, 331 Fort Johnson Road, Charleston, SC 29412, USA.
| | - Paul V Zimba
- Department of Life Sciences, Texas A&M Corpus Christi, 6300 Ocean Drive, Corpus Christi, TX 78412, USA.
| | - Haiyin He
- Biosortia Pharmaceuticals, Hollings Marine Laboratory, 331 Fort Johnson Road, Charleston, SC 29412, USA.
| | - Peter D R Moeller
- Emerging Toxins Program, National Ocean Service/NOAA, Hollings Marine Laboratory, 331 Fort Johnson Road, Charleston, SC 29412, USA.
| |
Collapse
|
23
|
Liaimer A, Jensen JB, Dittmann E. A Genetic and Chemical Perspective on Symbiotic Recruitment of Cyanobacteria of the Genus Nostoc into the Host Plant Blasia pusilla L. Front Microbiol 2016; 7:1693. [PMID: 27847500 PMCID: PMC5088731 DOI: 10.3389/fmicb.2016.01693] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2016] [Accepted: 10/10/2016] [Indexed: 12/04/2022] Open
Abstract
Liverwort Blasia pusilla L. recruits soil nitrogen-fixing cyanobacteria of genus Nostoc as symbiotic partners. In this work we compared Nostoc community composition inside the plants and in the soil around them from two distant locations in Northern Norway. STRR fingerprinting and 16S rDNA phylogeny reconstruction showed a remarkable local diversity among isolates assigned to several Nostoc clades. An extensive web of negative allelopathic interactions was recorded at an agricultural site, but not at the undisturbed natural site. The cell extracts of the cyanobacteria did not show antimicrobial activities, but four isolates were shown to be cytotoxic to human cells. The secondary metabolite profiles of the isolates were mapped by MALDI-TOF MS, and the most prominent ions were further analyzed by Q-TOF for MS/MS aided identification. Symbiotic isolates produced a great variety of small peptide-like substances, most of which lack any record in the databases. Among identified compounds we found microcystin and nodularin variants toxic to eukaryotic cells. Microcystin producing chemotypes were dominating as symbiotic recruits but not in the free-living community. In addition, we were able to identify several novel aeruginosins and banyaside-like compounds, as well as nostocyclopeptides and nosperin.
Collapse
Affiliation(s)
- Anton Liaimer
- Department of Arctic and Marine Biology, Faculty of Biosciences, Fisheries and Economics, UiT-The Arctic University of NorwayTromsø, Norway
| | - John B. Jensen
- Department of Arctic and Marine Biology, Faculty of Biosciences, Fisheries and Economics, UiT-The Arctic University of NorwayTromsø, Norway
| | - Elke Dittmann
- Department of Microbiology, Institute for Biochemistry and Biology, University of PotsdamPotsdam, Germany
| |
Collapse
|
24
|
Freitas S, Martins R, Campos A, Azevedo J, Osório H, Costa M, Barros P, Vasconcelos V, Urbatzka R. Insights into the potential of picoplanktonic marine cyanobacteria strains for cancer therapies – Cytotoxic mechanisms against the RKO colon cancer cell line. Toxicon 2016; 119:140-51. [DOI: 10.1016/j.toxicon.2016.05.016] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2016] [Revised: 04/19/2016] [Accepted: 05/26/2016] [Indexed: 12/19/2022]
|
25
|
Gandola E, Antonioli M, Traficante A, Franceschini S, Scardi M, Congestri R. ACQUA: Automated Cyanobacterial Quantification Algorithm for toxic filamentous genera using spline curves, pattern recognition and machine learning. J Microbiol Methods 2016; 124:48-56. [PMID: 27012737 DOI: 10.1016/j.mimet.2016.03.007] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2016] [Revised: 03/10/2016] [Accepted: 03/16/2016] [Indexed: 11/26/2022]
Abstract
Toxigenic cyanobacteria are one of the main health risks associated with water resources worldwide, as their toxins can affect humans and fauna exposed via drinking water, aquaculture and recreation. Microscopy monitoring of cyanobacteria in water bodies and massive growth systems is a routine operation for cell abundance and growth estimation. Here we present ACQUA (Automated Cyanobacterial Quantification Algorithm), a new fully automated image analysis method designed for filamentous genera in Bright field microscopy. A pre-processing algorithm has been developed to highlight filaments of interest from background signals due to other phytoplankton and dust. A spline-fitting algorithm has been designed to recombine interrupted and crossing filaments in order to perform accurate morphometric analysis and to extract the surface pattern information of highlighted objects. In addition, 17 specific pattern indicators have been developed and used as input data for a machine-learning algorithm dedicated to the recognition between five widespread toxic or potentially toxic filamentous genera in freshwater: Aphanizomenon, Cylindrospermopsis, Dolichospermum, Limnothrix and Planktothrix. The method was validated using freshwater samples from three Italian volcanic lakes comparing automated vs. manual results. ACQUA proved to be a fast and accurate tool to rapidly assess freshwater quality and to characterize cyanobacterial assemblages in aquatic environments.
Collapse
Affiliation(s)
- Emanuele Gandola
- University of Rome Tor Vergata, Department of Biology, via della Ricerca Scientifica 1, 00133 Rome, Italy; Department of Mathematics, University of Rome Tor Vergata, via della Ricerca Scientifica 1, 00133 Rome, Italy.
| | - Manuela Antonioli
- University of Rome Tor Vergata, Department of Biology, via della Ricerca Scientifica 1, 00133 Rome, Italy; National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, Via Portuense, 292 00149 Rome, Italy; Freiburg Institute for Advanced Studies (FRIAS), University of Freiburg, Freiburg 79104, Germany
| | - Alessio Traficante
- The University of Manchester, Jodrell Bank Centre for Astrophysics, School of Physics and Astronomy, Manchester M13 9PL, UK
| | - Simone Franceschini
- University of Rome Tor Vergata, Department of Biology, via della Ricerca Scientifica 1, 00133 Rome, Italy
| | - Michele Scardi
- University of Rome Tor Vergata, Department of Biology, via della Ricerca Scientifica 1, 00133 Rome, Italy
| | - Roberta Congestri
- University of Rome Tor Vergata, Department of Biology, via della Ricerca Scientifica 1, 00133 Rome, Italy; AlgaRes, Spin off of University of Rome Tor Vergata, via della Ricerca Scientifica 1, 00133 Rome, Italy
| |
Collapse
|
26
|
Bertin MJ, Demirkiran O, Navarro G, Moss NA, Lee J, Goldgof GM, Vigil E, Winzeler EA, Valeriote FA, Gerwick WH. Kalkipyrone B, a marine cyanobacterial γ-pyrone possessing cytotoxic and anti-fungal activities. PHYTOCHEMISTRY 2016; 122:113-118. [PMID: 26632528 PMCID: PMC4724546 DOI: 10.1016/j.phytochem.2015.11.011] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/09/2015] [Revised: 11/12/2015] [Accepted: 11/19/2015] [Indexed: 05/11/2023]
Abstract
Bioassay-guided fractionation of two marine cyanobacterial extracts using the H-460 human lung cancer cell line and the OVC-5 human ovarian cancer cell line led to the isolation of three related α-methoxy-β, β'-dimethyl-γ-pyrones each containing a modified alkyl chain, one of which was identified as the previously reported kalkipyrone and designated kalkipyrone A. The second compound was an analog designated kalkipyrone B. The third was identified as the recently reported yoshinone A, also isolated from a marine cyanobacterium. Kalkipyrone A and B were obtained from a field-collection of the cyanobacterium Leptolyngbya sp. from Fagasa Bay, American Samoa, while yoshinone A was isolated from a field-collection of cyanobacteria (cf. Schizothrix sp.) from Panama. One-dimensional and two-dimensional NMR experiments were used to determine the overall structures and relative configurations of the kalkipyrones, and the absolute configuration of kalkipyrone B was determined by (1)H NMR analysis of diastereomeric Mosher's esters. Kalkipyrone A showed good cytotoxicity to H-460 human lung cancer cells (EC50=0.9μM), while kalkipyrone B and yoshinone A were less active (EC50=9.0μM and >10μM, respectively). Both kalkipyrone A and B showed moderate toxicity to Saccharomyces cerevisiae ABC16-Monster strain (IC50=14.6 and 13.4μM, respectively), whereas yoshinone A was of low toxicity to this yeast strain (IC50=63.8μM).
Collapse
Affiliation(s)
- Matthew J Bertin
- Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California, San Diego, 8615 Kennel Way, La Jolla, CA 92037, United States
| | - Ozlem Demirkiran
- Department of Pharmacognosy, Faculty of Pharmacy, Trakya University, Edirne 22030, Turkey
| | - Gabriel Navarro
- Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California, San Diego, 8615 Kennel Way, La Jolla, CA 92037, United States
| | - Nathan A Moss
- Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California, San Diego, 8615 Kennel Way, La Jolla, CA 92037, United States
| | - John Lee
- Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California, San Diego, 8615 Kennel Way, La Jolla, CA 92037, United States; Chemistry & Biochemistry Program, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, United States
| | - Gregory M Goldgof
- Department of Pediatrics, University of California, San Diego, School of Medicine, 9500 Gilman Drive, La Jolla, CA 92093, United States
| | - Edgar Vigil
- Department of Pediatrics, University of California, San Diego, School of Medicine, 9500 Gilman Drive, La Jolla, CA 92093, United States
| | - Elizabeth A Winzeler
- Department of Pediatrics, University of California, San Diego, School of Medicine, 9500 Gilman Drive, La Jolla, CA 92093, United States
| | - Fred A Valeriote
- Henry Ford Health System, Department of Internal Medicine, Josephine Ford Cancer Center, 440 Burroughs, Room 415, Detroit, MI 48202, United States
| | - William H Gerwick
- Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California, San Diego, 8615 Kennel Way, La Jolla, CA 92037, United States; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, United States.
| |
Collapse
|
27
|
Gangl D, Zedler JAZ, Rajakumar PD, Martinez EMR, Riseley A, Włodarczyk A, Purton S, Sakuragi Y, Howe CJ, Jensen PE, Robinson C. Biotechnological exploitation of microalgae. JOURNAL OF EXPERIMENTAL BOTANY 2015; 66:6975-90. [PMID: 26400987 DOI: 10.1093/jxb/erv426] [Citation(s) in RCA: 78] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/18/2023]
Abstract
Microalgae are a diverse group of single-cell photosynthetic organisms that include cyanobacteria and a wide range of eukaryotic algae. A number of microalgae contain high-value compounds such as oils, colorants, and polysaccharides, which are used by the food additive, oil, and cosmetic industries, among others. They offer the potential for rapid growth under photoautotrophic conditions, and they can grow in a wide range of habitats. More recently, the development of genetic tools means that a number of species can be transformed and hence used as cell factories for the production of high-value chemicals or recombinant proteins. In this article, we review exploitation use of microalgae with a special emphasis on genetic engineering approaches to develop cell factories, and the use of synthetic ecology approaches to maximize productivity. We discuss the success stories in these areas, the hurdles that need to be overcome, and the potential for expanding the industry in general.
Collapse
Affiliation(s)
- Doris Gangl
- Centre for Molecular Processing, School of Biosciences, University of Kent, Canterbury CT2 7NJ, UK
| | - Julie A Z Zedler
- Centre for Molecular Processing, School of Biosciences, University of Kent, Canterbury CT2 7NJ, UK
| | - Priscilla D Rajakumar
- Institute of Structural & Molecular Biology, University College London, Gower Street, London WC1E 6BT, UK
| | - Erick M Ramos Martinez
- Copenhagen Plant Science Centre, Department of Plant and Environmental Sciences, University of Copenhagen, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Copenhagen, Denmark
| | - Anthony Riseley
- Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1QW, UK
| | - Artur Włodarczyk
- Copenhagen Plant Science Centre, Department of Plant and Environmental Sciences, University of Copenhagen, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Copenhagen, Denmark
| | - Saul Purton
- Institute of Structural & Molecular Biology, University College London, Gower Street, London WC1E 6BT, UK
| | - Yumiko Sakuragi
- Copenhagen Plant Science Centre, Department of Plant and Environmental Sciences, University of Copenhagen, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Copenhagen, Denmark
| | - Christopher J Howe
- Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1QW, UK
| | - Poul Erik Jensen
- Copenhagen Plant Science Centre, Department of Plant and Environmental Sciences, University of Copenhagen, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Copenhagen, Denmark
| | - Colin Robinson
- Centre for Molecular Processing, School of Biosciences, University of Kent, Canterbury CT2 7NJ, UK
| |
Collapse
|
28
|
Salvador-Reyes LA, Luesch H. Biological targets and mechanisms of action of natural products from marine cyanobacteria. Nat Prod Rep 2015; 32:478-503. [PMID: 25571978 DOI: 10.1039/c4np00104d] [Citation(s) in RCA: 114] [Impact Index Per Article: 12.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Marine cyanobacteria are an ancient group of organisms and prolific producers of bioactive secondary metabolites. These compounds are presumably optimized by evolution over billions of years to exert high affinity for their intended biological target in the ecologically relevant organism but likely also possess activity in different biological contexts such as human cells. Screening of marine cyanobacterial extracts for bioactive natural products has largely focused on cancer cell viability; however, diversification of the screening platform led to the characterization of many new bioactive compounds. Targets of compounds have oftentimes been elusive if the compounds were discovered through phenotypic assays. Over the past few years, technology has advanced to determine mechanism of action (MOA) and targets through reverse chemical genetic and proteomic approaches, which has been applied to certain cyanobacterial compounds and will be discussed in this review. Some cyanobacterial molecules are the most-potent-in-class inhibitors and therefore may become valuable tools for chemical biology to probe protein function but also be templates for novel drugs, assuming in vitro potency translates into cellular and in vivo activity. Our review will focus on compounds for which the direct targets have been deciphered or which were found to target a novel pathway, and link them to disease states where target modulation may be beneficial.
Collapse
Affiliation(s)
- Lilibeth A Salvador-Reyes
- Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, Florida 32610, USA.
| | | |
Collapse
|
29
|
Abstract
This review covers the literature published in 2013 for marine natural products (MNPs), with 982 citations (644 for the period January to December 2013) referring to compounds isolated from marine microorganisms and phytoplankton, green, brown and red algae, sponges, cnidarians, bryozoans, molluscs, tunicates, echinoderms, mangroves and other intertidal plants and microorganisms. The emphasis is on new compounds (1163 for 2013), together with the relevant biological activities, source organisms and country of origin. Reviews, biosynthetic studies, first syntheses, and syntheses that lead to the revision of structures or stereochemistries, have been included.
Collapse
Affiliation(s)
- John W Blunt
- Department of Chemistry, University of Canterbury, Christchurch, New Zealand.
| | | | | | | | | |
Collapse
|
30
|
Srivastava A, Tiwari R, Srivastava V, Singh TB, Asthana RK. Fresh Water Cyanobacteria Geitlerinema sp. CCC728 and Arthrospira sp. CCC729 as an Anticancer Drug Resource. PLoS One 2015; 10:e0136838. [PMID: 26325186 PMCID: PMC4567175 DOI: 10.1371/journal.pone.0136838] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2015] [Accepted: 08/10/2015] [Indexed: 11/18/2022] Open
Abstract
An increasing number of cancer patients worldwide, especially in third world countries, have raised concern to explore natural drug resources, such as the less explored fresh water filamentous cyanobacteria. Six strains of cyanobacteria (Phormidium sp. CCC727, Geitlerinema sp. CCC728, Arthrospira sp. CCC729, Phormidium sp. CCC731, Phormidium sp. CCC730, and Leptolyngbya sp. CCC732) were isolated (paddy fields and ponds in the Banaras Hindu University, campus) and five strains screened for anticancer potential using human colon adenocarcinoma (HT29) and human kidney adenocarcinoma (A498) cancer cell lines. Geitlerinema sp. CCC728 and Arthrospira sp. CCC729 were the most potent as determined by examination of morphological features and by inhibition of growth by graded concentrations of crude extracts and thin-layer chromatography (TLC) eluates. Cell cycle analysis and multiplex assays using cancer biomarkers also confirmed Geitlerinema sp. CCC728 and Arthrospira sp. CCC729 as cancer drug resources. Apoptotic studies in the cells of A498 (cancer) and MCF-10A (normal human epithelial) exposed to crude extracts and TLC fractions revealed no significant impact on MCF-10A cells emphasizing its importance in the development of anticancer drug. Identification of biomolecules from these extracts are in progress.
Collapse
Affiliation(s)
- Akanksha Srivastava
- Centre of Advanced Study in Botany, Faculty of Science, Banaras Hindu University, Varanasi, 221005, India
| | - Ratnakar Tiwari
- Council Scientific and Industrial Research, Indian Institute of Toxicology Research, Lucknow, 226001, India
| | - Vikas Srivastava
- Council Scientific and Industrial Research, Indian Institute of Toxicology Research, Lucknow, 226001, India
| | - Tej Bali Singh
- Division of statistics, Institute of Medical science, Banaras Hindu University, Varanasi, 221005, India
| | - Ravi Kumar Asthana
- Centre of Advanced Study in Botany, Faculty of Science, Banaras Hindu University, Varanasi, 221005, India
- * E-mail:
| |
Collapse
|
31
|
Brito Â, Gaifem J, Ramos V, Glukhov E, Dorrestein PC, Gerwick WH, Vasconcelos VM, Mendes MV, Tamagnini P. Bioprospecting Portuguese Atlantic coast cyanobacteria for bioactive secondary metabolites reveals untapped chemodiversity. ALGAL RES 2015. [DOI: 10.1016/j.algal.2015.03.016] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
32
|
Pettit GR, Arce PM, Chapuis JC, Macdonald CB. Antineoplastic agents. 600. From the South Pacific Ocean to the silstatins. JOURNAL OF NATURAL PRODUCTS 2015; 78:510-523. [PMID: 25688575 DOI: 10.1021/np501004h] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
The recent advances in the development of antibody and other drug conjugates for targeted cancer treatment have further increased the need for powerful cancer cell growth inhibitors. Toward that objective we have extended our earlier discovery of the remarkable anticancer bacillistatins 1 and 2 from Bacillus silvestris to SAR and other structural modifications such as availability of a free hydroxy group for antibody-drug conjugate (ADC) and other prodrug linkage. That direction has resulted in seven structural modifications designated silstatins 1-8 (7a, 8a, 8b, 14a, 15a, 15b, 18a, and 18b), where the exceptional cancer cell growth inhibition of some of them are in the range GI50 10(-3)-10(-4) μM/mL. Silstatin 7 (18a) was converted to a glucuronic conjugate (28) that displayed an impressive reduction in toxicity during transport.
Collapse
Affiliation(s)
- George R Pettit
- Department of Chemistry and Biochemistry, Arizona State University, P.O. Box 871604, Tempe, Arizona 85287-1604, United States
| | - Pablo M Arce
- Department of Chemistry and Biochemistry, Arizona State University, P.O. Box 871604, Tempe, Arizona 85287-1604, United States
| | - Jean-Charles Chapuis
- Department of Chemistry and Biochemistry, Arizona State University, P.O. Box 871604, Tempe, Arizona 85287-1604, United States
| | - Christian B Macdonald
- Department of Chemistry and Biochemistry, Arizona State University, P.O. Box 871604, Tempe, Arizona 85287-1604, United States
| |
Collapse
|
33
|
Cagide E, Becher PG, Louzao MC, Espiña B, Vieytes MR, Jüttner F, Botana LM. Hapalindoles from the Cyanobacterium Fischerella: Potential Sodium Channel Modulators. Chem Res Toxicol 2014; 27:1696-706. [DOI: 10.1021/tx500188a] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Affiliation(s)
- Eva Cagide
- Departamento
de Farmacología, Facultad de Veterinaria, Universidad de Santiago de Compostela, 27002 Lugo, Spain
| | - Paul G. Becher
- Institute
of Plant Biology, Limnological
Station, University of Zürich, 8802 Kilchberg, Switzerland
| | - M. Carmen Louzao
- Departamento
de Farmacología, Facultad de Veterinaria, Universidad de Santiago de Compostela, 27002 Lugo, Spain
| | - Begoña Espiña
- Departamento
de Farmacología, Facultad de Veterinaria, Universidad de Santiago de Compostela, 27002 Lugo, Spain
| | - Mercedes R. Vieytes
- Departamento
de Fisiología, Facultad de Veterinaria, Universidad de Santiago de Compostela, 27002 Lugo, Spain
| | - Friedrich Jüttner
- Institute
of Plant Biology, Limnological
Station, University of Zürich, 8802 Kilchberg, Switzerland
| | - Luis M. Botana
- Departamento
de Farmacología, Facultad de Veterinaria, Universidad de Santiago de Compostela, 27002 Lugo, Spain
| |
Collapse
|
34
|
Hamzeh-Mivehroud M, Rahmani S, Feizi MAH, Dastmalchi S, Rashidi MR. In VitroandIn SilicoStudies to Explore Structural Features of Flavonoids for Aldehyde Oxidase Inhibition. Arch Pharm (Weinheim) 2014; 347:738-47. [DOI: 10.1002/ardp.201400076] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2014] [Revised: 04/30/2014] [Accepted: 05/05/2014] [Indexed: 01/10/2023]
Affiliation(s)
- Maryam Hamzeh-Mivehroud
- Biotechnology Research Center; Tabriz University of Medical Sciences; Tabriz Iran
- School of Pharmacy; Tabriz University of Medical Sciences; Tabriz Iran
| | - Seifullah Rahmani
- Department of Zoology; Faculty of Natural Science; University of Tabriz; Tabriz Iran
| | | | - Siavoush Dastmalchi
- Biotechnology Research Center; Tabriz University of Medical Sciences; Tabriz Iran
- School of Pharmacy; Tabriz University of Medical Sciences; Tabriz Iran
| | - Mohammad-Reza Rashidi
- Research Center for Pharmaceutical Nanotechnology; Tabriz University of Medical Sciences; Tabriz Iran
| |
Collapse
|
35
|
Anti-Chikungunya viral activities of aplysiatoxin-related compounds from the marine cyanobacterium Trichodesmium erythraeum. Mar Drugs 2014; 12:115-27. [PMID: 24394406 PMCID: PMC3917264 DOI: 10.3390/md12010115] [Citation(s) in RCA: 55] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2013] [Revised: 11/25/2013] [Accepted: 12/12/2013] [Indexed: 11/21/2022] Open
Abstract
Tropical filamentous marine cyanobacteria have emerged as a viable source of novel bioactive natural products for drug discovery and development. In the present study, aplysiatoxin (1), debromoaplysiatoxin (2) and anhydrodebromoaplysiatoxin (3), as well as two new analogues, 3-methoxyaplysiatoxin (4) and 3-methoxydebromoaplysiatoxin (5), are reported for the first time from the marine cyanobacterium Trichodesmium erythraeum. The identification of the bloom-forming cyanobacterial strain was confirmed based on phylogenetic analysis of its 16S rRNA sequences. Structural determination of the new analogues was achieved by extensive NMR spectroscopic analysis and comparison with NMR spectral data of known compounds. In addition, the antiviral activities of these marine toxins were assessed using Chikungunya virus (CHIKV)-infected cells. Post-treatment experiments using the debrominated analogues, namely compounds 2, 3 and 5, displayed dose-dependent inhibition of CHIKV when tested at concentrations ranging from 0.1 µM to 10.0 µM. Furthermore, debromoaplysiatoxin (2) and 3-methoxydebromoaplysiatoxin (5) exhibited significant anti-CHIKV activities with EC50 values of 1.3 μM and 2.7 μM, respectively, and selectivity indices of 10.9 and 9.2, respectively.
Collapse
|